| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AVEO PHARMACEUTICALS INC | 2,000,000 | 1,780,000 | 0.41% | ||
| 2 | ABBVIE INC | 32,000 | 2,018,000 | 0.46% | ||
| 3 | VIVUS INC | 2,573,943 | 2,934,000 | 0.68% | ||
| 4 | QUEST DIAGNOSTICS INC | 50,000 | 4,231,000 | 0.97% | ||
| 5 | Apricus Biosciences, Inc. | 14,479,052 | 4,898,000 | 1.13% | ||
| 6 | ADVAXIS INC COM NEW | 600,000 | 6,413,000 | 1.48% | ||
| 7 | AEGERION PHARMACEUTICALS INC | 2,649,000 | 7,867,000 | 1.81% | ||
| 8 | INTRA-CELLULAR THERAPIES INC | 675,000 | 10,286,000 | 2.37% | ||
| 9 | INNOVIVA INC COM | 1,000,000 | 10,990,000 | 2.53% | ||
| 10 | PACIRA PHARMACEUTICALS INC | 430,000 | 14,714,000 | 3.39% | ||
| 11 | ARRAY BIOPHARMA INC | 4,300,000 | 29,025,000 | 6.68% | ||
| 12 | MEDICINES CO | 1,752,000 | 66,120,000 | 15.23% | ||
| 13 | BIOGEN INC | 310,000 | 97,039,000 | 22.35% | ||
| 14 | ARIAD PHARMACEUTICALS ORD (NMS) | 12,850,000 | 175,916,000 | 40.51% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-16-086479, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
